Skip to content
Home/Companies/MedTech/Lymphatica Medtech
Lymphatica Medtech

Lymphatica Medtech

MedTech·Switzerland·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Lymphatica Medtech?

Lymphatica Medtech is currently owned by Panakes Partners SGR through Panakes Fund Purple (2021 vintage), since 2024.

Hand-verified · updated 2026-07-23

Panakes Partners SGR
Investor
Panakes Partners SGR
Panakes Fund Purple · 2021 · Life Sciences VC

Key facts

HQSwitzerland
SectorMedTech
StatusActive
Websitewww.lymphaticamedtech.com

More from Panakes Fund Purple

Other portfolio companies in the same fund.

Deepull
Active
MedTechSpain· 2025
Endovascular Engineering
Active
MedTechUS· 2025
NanoPhoria
Active
BiotechItaly· 2025
Tensive
Active
MedTechItaly· 2025
CorFlow Therapeutics
CorFlow Therapeutics
Active
MedTechSwitzerland· 2024
DISCO Pharmaceuticals
Active
BiotechSwitzerland· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Lymphatica Medtech

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Lymphatica Medtech?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Lymphatica Medtech.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue